About Xagenic
Xagenic is a Healthcare company based in Toronto (Canada) founded in 2010. Rapid molecular diagnostics for infectious diseases are delivered at point-of-care. Xagenic has raised $59.07 million across 5 funding rounds from investors including Qiagen, BDC and Ontario Centre of Innovation. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified.
Company details
Xagenic was founded in 2010 in Toronto, Canada, within the biotechnology sector focused on infectious disease diagnostics. A point-of-care platform is being developed for decentralized molecular testing, utilizing the X1 instrument and proprietary AuRA cartridges. Clinical specimens are processed through automated, enzyme-free nucleic acid detection after insertion into the system. Assays for various infectious diseases are also under development to support the platforms operations.
- Headquarters Toronto, Canada
- SectorsHealthcare
- Website xagenic.com
- Social LinkedIn
- Total Equity Funding$59.07M (USD)
in 5 rounds
- Latest Funding Round$11.78M (USD), Series C
Jul 2015
- InvestorsQiagen
& 8 more
Funding Insights of Xagenic
Xagenic has successfully raised a total of $59.07M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $11.78 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $59.07M
- Total Rounds 5
- Last Round Series C — $11.78M
- First Round $2.2M
(Oct 2010)
- Investors Count 9
All 5 funding rounds of Xagenic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2015 | $11.78M | Series C | – | BDC, Domain Associates | – |
| Jul 2014 | $25.5M | Series B | – | BDC | |
| Dec 2013 | $9.59M | Series A | – | – | – |
| Jan 2012 | $10M | Series A | – | Qiagen, CTI Life Sciences Fund | – |
| Oct 2010 | $2.2M | Seed | – | TIAP |
9 investors in total: 9 institutional.
Investors in Xagenic
Xagenic has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, BDC and Ontario Centre of Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Venture capital investments are made in life sciences companies. | ctisciences.com | Montreal, Canada | ||
| ontariocapitalgrowth.ca | ||||
Early-stage health science technologies are developed into business ventures by TIAP. | tiap.ca | Toronto, Canada | ||
Commercial banking services for small and medium-sized enterprises are provided. | 1944 | bdc.ca | Montreal, Canada | |
Products and reagents for molecular diagnostic assays are supplied. | 1984 | qiagen.com | Hilden, Germany | |
| htx.ca | ||||
High-impact translational cancer research is conducted and enabled. | 2005 | oicr.on.ca | Toronto, Canada | |
Research and development services are delivered to an innovation community. | 1987 | oc-innovation.ca | Toronto, Canada |
Investor details for Xagenic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xagenic
3 dated milestones of Xagenic across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Xagenic is founded.
- Funding First funding round of $2.2M.
- Funding Latest funding round, Series C, of $11.8M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Xagenic
Xagenic was founded in 2010.
Xagenic is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Xagenic is a funded company, having raised a total of $59.07M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.2M, raised on Oct 2010.
Xagenic was founded in 2010 in Toronto, Canada, within the biotechnology sector focused on infectious disease diagnostics. A point-of-care platform is being developed for decentralized molecular testing, utilizing the X1 instrument and proprietary AuRA cartridges. Clinical specimens are processed through automated, enzyme-free nucleic acid detection after insertion into the system. Assays for various infectious diseases are also under development to support the platforms operations.
Xagenic has 9 investors. Key investors include Qiagen, BDC, Ontario Centre of Innovation, Ontario Institute for Cancer Research, and Domain Associates.